LaJolla Pharmaceutical Company
- Employees
- 51–200
- Founded
- 1989
- Business Model
- B2B
- Website
- ljpc.com
About
La Jolla Pharmaceutical Company, founded in 1989, is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for patients with life-threatening diseases, including antibody-related and cardiovascular disorders. Its flagship product, GIAPREZA (angiotensin II), is approved to increase blood pressure in adults with septic or other distributive shock. The company was acquired by Innoviva, Inc. in August 2022 for $6.23 per share and now operates as a subsidiary of Innoviva, headquartered in Waltham, Massachusetts.
Summary
LaJolla Pharmaceutical Company is a Biotech company, founded in 1989.
Funding History
May 2018
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lajolla-pharmaceutical-company"><img src="https://indexed.vc/api/badge/company/lajolla-pharmaceutical-company" alt="LaJolla Pharmaceutical Company on Indexed.vc" width="260" height="76" /></a>